Physician profile
Thomas G Baker
NPI 1518305689
$3,707.68
in general payments reported to CMS, 2019-2025
40 companies · $792 in 2025
The $792 reported for 2025 was more than what 94% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $124 · 2021: $375 · 2022: $660 · 2023: $746 · 2024: $793 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,331.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $778.15 | 2021-2025 | Vraylar, Dalvance, Ubrelvy |
| Novo Nordisk INC | $406.34 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $294.29 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $252.31 | 2023-2024 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $232.99 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $157.16 | 2019-2025 | |
| Amgen INC. | $154.07 | 2019-2025 | Repatha, Otezla, Evenity |
| Exact Sciences Corporation | $121.51 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $121.19 | 2023-2025 | |
| Pfizer INC. | $76.36 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $75.45 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $74.57 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.92 | 2019-2024 | Ofev |
| E.R. Squibb & Sons, L.L.C. | $62.78 | 2020-2022 | |
| Dynavax Technologies Corporation | $60.62 | 2023-2024 | Heplisav-B |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.